Cambridge Network Board
(Chairman) Dr. Andy Harter
Andy Harter is an innovator and entrepreneur, responsible among other things for VNC software which allows remote control of one computer screen from another. The technology is on over two billion devices, is on more different kinds of computer than any other application and is an official part of the internet. Before that, Andy was director of research and engineering at the influential AT&T Cambridge Laboratory and responsible for several ground-breaking technologies. He has a PhD from the University of Cambridge where he is a Fellow of the Computer Laboratory and St Edmund’s College. He is a Trustee of both the Royal Academy of Engineering and the Institution of Engineering and Technology.
Shareholder Board Members
|Dr. Hermann Hauser, Amadeus Capital Partners
One of the original Founders of the Cambridge Network and a Director since the Network’s inception in 1998, Hermann co-founded Amadeus Capital Partners in 1997 with Anne Glover and Peter Wynn. In his long and successful history as an entrepreneur and venture capitalist, Hermann has founded or co-founded companies in a wide range of technology sectors.
|Colin Manktelow, NW Brown
Colin is a main board director of NW Brown Group and a director of NW Brown & Co. After starting his career in banking, Colin joined a Cambridge-based stock broking firm which became the nucleus of NW Brown & Co; Colin has been with the firm since 1987 and manages investment portfolios for clients, charities and pension funds. He is a Chartered Fellow of the Chartered Institute for Securities and Investments and holds the Institute’s Diploma.
|Dr. Peter Taylor, TTP
Peter is Managing Director of TTP Group. In 1987 he was one of the founders of TTP and subsequently built the science-based half of it. He is on the board of a number of external organisations involved in education, the Arts, entrepreneurship, and promotion of high-tech industry. Peter has been responsible for product and technology developments in major markets including healthcare, communications and consumer products.
|Prof. Nigel Slater, University of Cambridge
Nigel is the Pro-Vice-Chancellor for Enterprise and the Region in the University of Cambridge, the 1999 Professor of Chemical Engineering and the former Head of the Department of Chemical Engineering and Biotechnology. He is a Fellow of the Royal Academy of Engineering and the Institution of Chemical Engineers and is a Chartered Engineer. He is a member of the Greater Cambridge City Deal Board and the board of Cambridge Enterprise Ltd. Nigel leads the research activities at the Cambridge Unit for Bioscience Engineering at the University of Cambridge and has a particular interest in the manufacture and formulation of biopharmaceuticals including proteins, DNA, viruses and cells.
|Lee Welham, Deloitte
Lee Welham is a partner in the Deloitte Cambridge office with 14 years’ experience in serving a range of businesses in the FTSE, AIM and high growth private market sectors. Lee leads the Deloitte Equity Capital Markets group in Cambridge which provides a range of services to companies with an aspiration to IPO. He has led and been involved in all major areas of capital markets work including acquisition due diligence; reporting accountant work and demerger projects.
Individual Board Members
|Dr. David Cleevely
One of the original Founder Directors of the Cambridge Network and its Chair for several years, David is the Chairman of CRFS, which he co-founded in July 2007, and the founder and former Chairman of telecoms consultancy Analysys (acquired by Datatec International in 2004). He has been a prime mover behind Cambridge Network, co-founder of Cambridge Wireless, co-founder and Chairman of Cambridge Angels and is a member of the IET Communications Policy Panel. In October 2014 he was elected Chairman of Raspberry Pi.
|Dr. Andrew Lynn, The Centre for Entrepreneurial Learning (CfEL)
Andrew is a Canadian entrepreneur who has founded and led successful businesses in the life sciences and clean tech fields. As CEO of Orthomimetics he led the sale to TiGenix; one of the most successful small-cap exits of 2009 worldwide. More recently he has served as CEO of University of Cambridge spin-out CamGaN and led a process that culminated in CamGaN's rapid and profitable acquisition by Plessey Semiconductors. Andrew is an Entrepreneur in Residence at the Judge Business School.
|Prof. Iain Martin, Anglia Ruskin University
After a spell as Lecturer in Surgery at the University of Leeds, in 2000 Professor Martin moved to the University of Auckland, New Zealand, as Professor of Surgery. Over the next 13 years, whilst at the University of Auckland, he held a variety of roles including Dean of the Faculty of Medical and Health Sciences and Deputy Vice Chancellor with responsibility for external and international engagement. In 2012 he moved to the University of New South Wales in Sydney, Australia as Deputy Vice Chancellor Academic, a position he held until his appointment as Vice Chancellor of Anglia Ruskin University in 2016
| Caroline Rowland, ARM
Caroline Rowland joined ARM in September 2014 and is currently Global People Services Director where she leads a talented team of HR Business Partners, HR Managers and HR shared services to manage the strategic and tactical deployment of HR activities across ARM. Prior to joining ARM, Caroline undertook a variety of different HR roles at Diageo, the worlds largest drinks company, for eight years including HR Business Partnering, Talent & Reward roles.
|Vicki Sanderson, Marshall Aerospace and Defence Group
Vicki is part of the Marshall Group's senior management team and leads the Group's strategic HR programme driving the management of its global Human Resources, training and development activities worldwide. With more than 20 years of experience in Human Resources Vicki brings a vast amount of people management expertise and cultural knowledge to the company. Vicki has achieved a BA in History and a CIPD.
Dr Andy Williams, AstraZeneca/MedImmune
|Ken Woodberry, Microsoft Research
Ken is Deputy Managing Director at Microsoft's Cambridge Research Lab with responsibility for the lab's business-facing activities, including technology transfer, incubation, licensing, spin-outs, and other models for utilising the intellectual property generated by the lab's research groups. Woodberry joined Microsoft Research in September 2002 from RealVNC, a start-up he co-founded with colleagues from AT&T Laboratories in Cambridge.
|David Mardle, Taylor Wessing (Company Secretary)
David is a partner in Taylor Wessing's market-leading Corporate Technology team and advises primarily on corporate transactions, in particular trade sales, and equity funding transactions – both for funders and companies seeking finance. His clients include major technology and life sciences companies, plus some of Europe's highest-profile growth companies, and also major investors. He was one of the founders of TW's Cambridge office
Cambridge Network Limited is a company registered in England under Company No. 3400152
Cambridge Business Park
VAT No. 876 3375 84